BofA cuts ratings on four biopharma stocks over valuation and catalyst concerns

Investing_ng | 30-06-2026 10:17am |

BofA cuts ratings on four biopharma stocks over valuation and catalyst concerns

Related Articles

Naira exchange rate today, May 20, 2026:... Top,business
Oceanhawk Acquisition prices $160 millio... Business
Tajudeen Abbas’ resounding APC primary... Top,politics
"Charlie was about to update his will": ... Top,politics
Former Benue Speaker, Dajoh dumps APC fo... Top,politics
Fire Breaks Out At Russia's Syzran Oil R... Environment

Stay Updated with the Latest News!

Don't miss out on breaking stories and in-depth articles.

See the latest News